AI takes charge of data, but challenges linger
For years, one of the biggest barriers to effectively implementing artificial intelligence (AI) into clinical trial data management has been…
Analysis
OCT DACH 2025: Geopolitics, trial equity and technology take centre stage
Breyanzi for the Treatment of Large B-cell Lymphoma, US
FORZINITY (elamipretide) for Muscle Strength in Barth syndrome, USA
Public sector R&D cuts could be the “silent economic killers” of US exceptionalism
HERNEXEOS (zongertinib tablets) for the Treatment of HER-2 Mutant Advanced NSCLC, USA
